Stockscreener 앱 받기
28.50
2.30%
-0.67
Alkermes Plc 주식(ALKS)의 최신 뉴스
Retail Surge: Why global investors buy Alkermes plc 8AK stockCEO Change & Expert Curated Trade Ideas - moha.gov.vn
History Review: Will Alkermes plc 8AK stock test record highs in 2025Watch List & High Conviction Investment Ideas - moha.gov.vn
BlackRock increases stake in Alkermes to 17% By Investing.com - Investing.com South Africa
BlackRock increases stake in Alkermes to 17% - Investing.com
Stempoint Capital LP Acquires 158,772 Shares of Alkermes plc $ALKS - MarketBeat
First Trust Advisors LP Has $39.98 Million Stock Holdings in Alkermes plc $ALKS - MarketBeat
Alkermes, Avadel Pharmaceuticals merger gets HSR clearance in US - MLex
Avadel Pharmaceuticals Acquisition by Alkermes Advances - TradingView
Are Investors Undervaluing Alkermes (ALKS) Right Now? - sharewise.com
(ALKS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Schroder Investment Management Group Invests $1.39 Million in Alkermes plc $ALKS - MarketBeat
Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid - MSN
Norges Bank Invests $53.33 Million in Alkermes plc $ALKS - MarketBeat
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Avadel Pharmaceuticals plc and Alkermes plc Announce Proposed Transaction for Acquisition - Quiver Quantitative
Announcement relating to despatch of Rule 15 proposal - The Manila Times
Avadel (NASDAQ: AVDL) sends Rule 15 proposal to equity holders in Alkermes deal - Stock Titan
Capital Fund Management S.A. Makes New $1.14 Million Investment in Alkermes plc $ALKS - MarketBeat
Will Alkermes plc (8AK) stock sustain bullish trend into 2025Fed Meeting & Smart Money Movement Tracker - Newser
ALKS: Elixirxton demonstrates strong efficacy, safety, and dosing flexibility for narcolepsy and hypersomnolence - TradingView
Avadel Pharmaceuticals Announces Mailing of Definitive Proxy Statement Regarding Proposed Acquisition by Alkermes - Quiver Quantitative
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting - Benzinga
Avadel (Nasdaq: AVDL) mails proxy, sets Jan. 12 scheme and EGM on Alkermes deal - Stock Titan
VP Hopkinson Files To Sell 3,748 Of Alkermes PLC [ALKS] - TradingView
Mackenzie Financial Corp Acquires 53,323 Shares of Alkermes plc $ALKS - MarketBeat
Evercore Healthcare Conference - marketscreener.com
How Alkermes plc (8AK) stock valuation compares with sectorQuarterly Profit Report & Daily Profit Focused Screening - Newser
Is Alkermes plc (8AK) stock a safe buy pre earningsMarket Growth Summary & Real-Time Sentiment Analysis - Newser
Insider Selling: Alkermes (NASDAQ:ALKS) EVP Sells 4,000 Shares of Stock - MarketBeat
Regeneron, Tessera to advance gene editing therapy for AATD: Deals Report - BioCentury
How supply chain issues affect Alkermes plc stockPortfolio Performance Report & Real-Time Stock Movement Alerts - Newser
Should Alkermes (ALKS) Investors Reassess Prospects After Raised 2025 Guidance and Strong Q3 Results? - Yahoo Finance
Is Alkermes plc (8AK) stock among top earnings playsQuarterly Trade Review & Real-Time Volume Surge Alerts - Newser
Insider Sell: Craig Hopkinson Sells 4,000 Shares of Alkermes PLC (ALKS) - GuruFocus
Alkermes plc. Officer Sells 4,000 Shares - TradingView
VP Hopkinson Sells 4,000 ($117.2K) Of Alkermes PLC [ALKS] - TradingView
Avadel Pharmaceuticals plc Announces Scheme Meeting for Alkermes Acquisition Proposal - Quiver Quantitative
Avadel Pharmaceuticals (Nasdaq: AVDL) to hold Scheme and EGM on Alkermes takeover Jan. 12 - Stock Titan
Rhumbline Advisers Purchases 17,660 Shares of Alkermes plc $ALKS - MarketBeat
Legal & General Group Plc Sells 17,227 Shares of Alkermes plc $ALKS - MarketBeat
Loomis Sayles & Co. L P Sells 330,389 Shares of Alkermes plc $ALKS - MarketBeat
JPMorgan Chase & Co. Trims Stock Position in Alkermes plc $ALKS - MarketBeat
Alkermes plc $ALKS Shares Sold by Ensign Peak Advisors Inc - MarketBeat
JPMorgan discloses securities dealings in Avadel Pharmaceuticals - Investing.com
Alkermes Eyes Global Phase 3 Trial After Encouraging Data From Sleep Disorder Study - Sahm
Why Is Alkermes (ALKS) Down 5.5% Since Last Earnings Report? - sharewise.com
Avadel (AVDL) Drops 6.7% on Lack of Leads - Finviz
Lundbeck Concedes Avadel Bidding War, But Remains On The Hunt - Citeline News & Insights
Alkermes (ALKS) Expected to Complete Avadel Acquisition in Early 2026 - GuruFocus
How (ALKS) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Alkermes to Participate in Two Upcoming December 2025 Investor Conferences - BioSpace
Alkermes to Participate in Two Upcoming Investor Conferences - Business Wire
United StatesGoodwin Advises Avadel Pharmaceuticals On Increased Offer From Alkermes - Mondaq
Magnetar Financial LLC Acquires Shares of 123,678 Alkermes plc $ALKS - MarketBeat
TD Cowen Asserts Buy Rating as Alkermes plc (ALKS) Delivers Topline Results for Narcolepsy Treatment - MSN
How Analysts See the Alkermes Story Changing After Acquisition Moves and New Narcolepsy Data - Yahoo Finance
1.48%
0.09%
자본화:
|
볼륨(24시간):